Ignite Creation Date:
2025-12-25 @ 3:54 AM
Ignite Modification Date:
2026-05-12 @ 11:00 AM
Study NCT ID:
NCT06455202
Status:
RECRUITING
Last Update Posted:
2025-12-18
First Post:
2024-06-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)
Sponsor:
Celldex Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CDX0159-13
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None